Janux Therapeutics, Inc. - Common Stock (JANX)
CUSIP: 47103J105
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 60,117,449
- Total 13F shares
- 26,499,088
- Share change
- +1,755,863
- Total reported value
- $571,208,440
- Price per share
- $21.63
- Number of holders
- 44
- Value change
- +$35,499,490
- Number of buys
- 32
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 47103J105?
CUSIP 47103J105 identifies JANX - Janux Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 47103J105:
Top shareholders of JANX - Janux Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
14%
|
8,670,644
|
$216,333,000 | — | 30 Jun 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
5.8%
|
3,466,386
|
$86,486,000 | — | 30 Jun 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.4%
|
2,668,207
|
$64,522,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.1%
|
1,886,712
|
$46,239,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
3.1%
|
1,843,564
|
$45,997,000 | — | 30 Jun 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.3%
|
1,411,975
|
$35,229,000 | — | 30 Jun 2021 | |
| BVF INC/IL |
13F
|
Company |
2%
|
1,176,681
|
$29,358,000 | — | 30 Jun 2021 | |
| Bregua Corp |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,749,250
|
$22,008,098 | — | 15 Jun 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.2%
|
700,000
|
$17,465,000 | — | 30 Jun 2021 | |
| Samsara BioCapital, LLC |
13F
|
Company |
1%
|
607,949
|
$15,168,000 | — | 30 Jun 2021 | |
| Logos Global Management LP |
13F
|
Company |
0.91%
|
547,122
|
$13,651,000 | — | 30 Jun 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.75%
|
450,000
|
$11,228,000 | — | 30 Jun 2021 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.74%
|
446,266
|
$11,134,000 | — | 30 Jun 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.56%
|
334,260
|
$8,340,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.18%
|
109,947
|
$2,743,000 | — | 30 Jun 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.14%
|
86,695
|
$2,163,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.13%
|
75,257
|
$1,878,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
69,000
|
$1,722,000 | — | 30 Jun 2021 | |
| LMR Partners LLP |
13F
|
Company |
0.09%
|
57,000
|
$1,422,000 | — | 30 Jun 2021 | |
| Pinz Capital Management, LP |
13F
|
Company |
0.05%
|
32,100
|
$801,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.05%
|
28,976
|
$723,000 | — | 30 Jun 2021 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.04%
|
24,567
|
$613,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
22,017
|
$549,000 | — | 30 Jun 2021 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.02%
|
14,309
|
$357,000 | — | 30 Jun 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.02%
|
9,165
|
$229,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2,048
|
$52,000 | — | 30 Jun 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,300
|
$32,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
646
|
$16,000 | — | 30 Jun 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
353
|
$9,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
100
|
$2,000 | — | 30 Jun 2021 |
Institutional Holders of Janux Therapeutics, Inc. - Common Stock (JANX) as of Q3 2021
As of 30 Sep 2021,
Janux Therapeutics, Inc. - Common Stock (JANX) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,499,088 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., FMR LLC, ORBIMED ADVISORS LLC, JANUS HENDERSON GROUP PLC, CITADEL ADVISORS LLC, EcoR1 Capital, LLC, BVF INC/IL, BlackRock Inc., VANGUARD GROUP INC, and 5AM Venture Management, LLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
29
Q3 2021 holders
44
Holder diff
15
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.